Limitations and challenges in treatment of acute chemical warfare agent poisoning

Chemico-Biological Interactions

Volumn 206, Issue 3, 2013, Pages 435-443

  Thiermann, Horst ^a   Worek, Franz ^a   Kehe, Kai ^a  

^a BUNDESWEHR INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (Germany)

Author keywords

Acetylcholinesterase; Chemical warfare agents; Human; Organophosphorus compounds; Sulfur mustard; Treatment

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ACETYLCHOLINESTERASE; ATROPINE; CHEMICAL WARFARE AGENT; CYCLOSARIN; DIAZEPAM; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; MUSTARD GAS; OBIDOXIME; OXIME DERIVATIVE; PARAOXON; PLACEBO; PRALIDOXIME; SARIN; SOMAN; TABUN; TOXIC SUBSTANCE; TRIMEDOXIME;

ARTICLE; AUTOINJECTOR; CHEMICAL STRUCTURE; CHEMICAL WARFARE; CONTINUOUS INFUSION; DEBRIDEMENT; DROWSINESS; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSE INCREASE; DRUG TOLERABILITY; DRY SKIN; EMERGENCY CARE; ENZYME ACTIVITY; ENZYME INHIBITION; GAS POISONING; HUMAN; LABORATORY DIAGNOSIS; LOADING DRUG DOSE; MEDICAL DECISION MAKING; MEMORY DISORDER; MYDRIASIS; PARALYSIS; PHYSICAL CHEMISTRY; SEIZURE; SELF INJECTION; SKIN DECONTAMINATION; SKIN TOXICITY; SKIN TRANSPLANTATION; SWEAT GLAND DISEASE; SYRIAN ARAB REPUBLIC; SYRINGE; TACHYCARDIA; TERRORISM; XEROSTOMIA;

ACETYLCHOLINESTERASE; CHEMICAL WARFARE AGENTS; HUMAN; ORGANOPHOSPHORUS COMPOUNDS; SULFUR MUSTARD; TREATMENT;

ANTIDOTES; ATROPINE; CHEMICAL WARFARE; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; DECONTAMINATION; HUMANS; MUSTARD GAS; ORGANOTHIOPHOSPHORUS COMPOUNDS; OXIMES; SARIN;

EID: 84890123524     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2013.09.015     Document Type: Article

References (64)

1. H.H. Kuehl Defense Protection against Chemical, Biological, Radiological and Nuclear Threats in a Changing Security Environment 2012 F:A:Z:-Institut für Management Frankfurt
2. A.T. Tu Chemical Terrorism: Horrors in Tokyo Subway and Matsumoto City 2002 Alaken Inc. Fort Collins
3. M, Meselson, J.P. Robinson, Chemische Waffen und Rüstungskontrolle, Verständliche Forschung Rüstung und Abrüstung. Spektrum der Wissenschaft, Speyer, 198 (1983) 88-99.
4. Organisation for the Prohibition of Chemical Wepons. Member states of the CWC. June 2013. 2013.
5. I. Hendler, O. Nahtomi, E. Segal, A. Perel, M. Wiener, and J. Meyerovitch The effect of full protective gear on intubation performance by hospital medical personnel Mil. Med. 165 2000 272 274 (Pubitemid 30228175)
6. R. Ben-Abraham, and A.A. Weinbroum Laryngeal mask airway control versus endotracheal intubation by medical personnel wearing protective gear Am. J. Emerg. Med. 22 2004 24 26 (Pubitemid 38146305)
7. F. Worek, P. Eyer, and H. Thiermann Determination of acetylcholinesterase activity by the Ellman assay: a versatile tool for in vitro research on medical countermeasures against organophosphate poisoning Drug Test. Anal. 4 2012 282 291
8. P. Taylor, and Z. Radic The cholinesterases: from genes to proteins Annu. Rev. Pharmacol. Toxicol. 34 1994 281 320
9. S.R. Mortensen, S. Brimijoin, M.J. Hooper, and S. Padilla Comparison of the in vitro sensivitiy of rat acetylcholinesterase to chlorpyrifos-oxon: what do tissue IC50 values represent? Toxicol. Appl. Pharmacol. 148 1998 46 49 (Pubitemid 28072774)
10. H. Thiermann, T. Seeger, S. Gonder, N. Herkert, B. Antkowiak, T. Zilker, F. Eyer, and F. Worek Assessment of neuromuscular dysfunction during poisoning by organophosphorus compounds Chem. Biol. Interact. 187 2010 265 269
11. H. Thiermann, T. Zilker, F. Eyer, N. Felgenhauer, P. Eyer, and F. Worek Monitoring of neuromuscular transmission in organophosphate pesticide-poisoned patients Toxicol. Lett. 191 2009 297 304
12. F. Worek, M. Baumann, B. Pfeiffer, N. Aurbek, F. Balszuweit, and H. Thiermann Cholinesterase kit for field diagnosis of organophosphate exposure Medical corps international forum, challenge CBRN medical defense international 1 2013 4 6
13. P.W. Taylor, B.J. Lukey, C.R. Clark, R.B. Lee, and R.R. Roussel Field verification of test-mate ChE Mil. Med. 168 2003 314 319 (Pubitemid 36438370)
14. B.N. Rajapakse, H. Thiermann, P. Eyer, F. Worek, S.J. Bowe, A.H. Dawson, and N.A. Buckley Evaluation of the test-mate ChE (cholinesterase) field kit in acute organophosphorus poisoning Ann. Emerg. Med. 58 2011 559 564
15. N. Aurbek, H. Thiermann, F. Eyer, P. Eyer, and F. Worek Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: A kinetic analysis Toxicology 259 2009 133 139
16. M. Koller, C. Becker, H. Thiermann, and F. Worek GC-MS and LC-MS analysis of nerve agents in body fluids: intra-laboratory verification test using spiked plasma and urine samples J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 878 2010 1226 1233
17. M. Balali-Mood, and K. Balali-Mood Nerve agents J. Brent, K.L. Wallace, K.K. Burkhart, S.D. Phillips, J.W. Donovan, Critical Care Toxicology: Diagnosis and Mangement 2005 Elsevier Mosby Philadelphia 1379 1394
18. N.M. Herkert, H. Thiermann, and F. Worek In vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species Toxicol. Lett. 206 2011 41 46
19. Human Right Watch, Genocide in Iraq: The Anfal Campaign Against the Kurds, July 1993, Available from: < http://www.refworld.org/docid/47fdfb1d0. html > [accessed 28 June 2013].
20. F.R. Sidell Nerve agents F.R. Sidell, E.T. Takafuj, D.R. Franz, Medical Aspects of Chemical and Biological Warfare 1997 Office of The Surgeon General at TMM Publications Washington, DC 129 179
21. M. Eddleston, A. Dawson, L. Karalliedde, W. Dissanayake, A. Hittarage, S. Azher, and N.A. Buckley Early management after self-poisoning with an organophosphorus or carbamate pesticide - a treatment protocol for junior doctors Crit. Care 8 2004 R391 R397
22. M. Eddleston, N.A. Buckley, H. Checketts, L. Senarathna, F. Mohamed, M.H. Sheriff, and A. Dawson Speed of initial atropinisation in significant organophosphorus pesticide poisoning-a systematic comparison of recommended regimens J. Toxicol. Clin. Toxicol. 42 2004 865 875 (Pubitemid 39426213)
23. J.S. Rotenberg, and J. Newmark Nerve agent attacks on children: diagnosis and management Pediatrics 112 2003 648 658 (Pubitemid 37082120)
24. H. Thiermann, L. Szinicz, P. Eyer, N. Felgenhauer, T. Zilker, and F. Worek Lessons to be learnt from organophosphorus pesticide poisoning for the treatment of nerve agent poisoning Toxicology 233 2007 145 154 (Pubitemid 46498387)
25. F. Worek, H. Thiermann, L. Szinicz, and P. Eyer Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes Biochem. Pharmacol. 68 2004 2237 2248 (Pubitemid 39446151)
26. F. Eyer, F. Worek, P. Eyer, N. Felgenhauer, M. Haberkorn, T. Zilker, and H. Thiermann Obidoxime in acute organophosphate poisoning: 1 - clinical effectiveness Clin. Toxicol. (Phila) 47 2009 798 806
27. H. Thiermann, F. Worek, P. Eyer, F. Eyer, N. Felgenhauer, and T. Zilker Obidoxime in acute organophosphate poisoning: 2 - PK/PD relationships Clin. Toxicol. (Phila) 47 2009 807 813
28. F. Worek, L. Szinicz, P. Eyer, and H. Thiermann Evaluation of oxime efficacy in nerve agent poisoning: development of a kinetic-based dynamic model Toxicol. Appl. Pharmacol. 209 2005 193 202 (Pubitemid 41713944)
29. H. Thiermann, L. Szinicz, F. Eyer, F. Worek, P. Eyer, N. Felgenhauer, and T. Zilker Modern strategies in therapy of organophosphate poisoning Toxicol. Lett. 107 1999 233 239 (Pubitemid 29276906)
30. M. Eddleston, P. Eyer, F. Worek, E. Juszczak, N. Alder, F. Mohamed, L. Senarathna, A. Hittarage, S. Azher, K. Jeganathan, S. Jayamanne, M.L. von, A.H. Dawson, M.H. Sheriff, and N.A. Buckley Pralidoxime in acute organophosphorus insecticide poisoning-a randomised controlled trial PLoS Med. 6 2009 e1000104
31. F. Worek, and H. Thiermann The value of novel oximes for treatment of poisoning by organophosphorus compounds Pharmacol. Ther. 139 2013 249 259
32. K.V. Niessen, J.E. Tattersall, C.M. Timperley, M. Bird, C. Green, T. Seeger, H. Thiermann, and F. Worek Interaction of bispyridinium compounds with the orthosteric binding site of human alpha7 and Torpedo californica nicotinic acetylcholine receptors (nAChRs) Toxicol Lett. 206 2011 100 104
33. K.V. Niessen, J.E. Tattersall, C.M. Timperley, M. Bird, C. Green, H. Thiermann, and F. Worek Competition radioligand binding assays for the investigation of bispyridinium compound affinities to the human muscarinic acetylcholine receptor subtype 5 (hM(5)) Drug Test. Anal. 4 2012 292 297
34. T. Seeger, M. Eichhorn, M. Lindner, K.V. Niessen, J.E. Tattersall, C.M. Timperley, M. Bird, A.C. Green, H. Thiermann, and F. Worek Restoration of soman-blocked neuromuscular transmission in human and rat muscle by the bispyridinium non-oxime MB327 in vitro Toxicology 294 2012 80 84
35. T. Zilker Klinische Toxikologie für die Notfall- und Intensivmedizin 2008 UNI-MED Verlag Ag Bremen
36. J.H. McDonough Jr., and T.M. Shih Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology Neurosci. Biobehav. Rev. 21 1997 559 579 (Pubitemid 27458800)
37. T. Myhrer, S. Enger, M. Jonassen, and P. Aas Enhanced efficacy of anticonvulsants when combined with levetiracetam in soman-exposed rats Neurotoxicology 32 2011 923 930
38. T. Myhrer, S. Enger, and P. Aas Modulators of metabotropic glutamate receptors microinfused into perirhinal cortex: anticonvulsant effects in rats challenged with soman Eur. J. Pharmacol. 636 2010 82 87
39. T. Okumura, N. Takasu, S. Ishimatsu, S. Miyanoki, A. Mitsuhashi, K. Kumada, K. Tanaka, and S. Hinohara Report on 640 victims of the Tokyo subway sarin attack Ann. Emerg. Med. 28 1996 129 135 (Pubitemid 26287069)
40. H. Thiermann, U. Mast, R. Klimmek, P. Eyer, A. Hibler, R. Pfab, N. Felgenhauer, and T. Zilker Cholinesterase status, pharmacokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients Hum. Exp. Toxicol. 16 1997 473 480 (Pubitemid 27393996)
41. G. Reiter, J. Mikler, I. Hill, K. Weatherby, H. Thiermann, and F. Worek Simultaneous quantification of VX and its toxic metabolite in blood and plasma samples and its application for in vivo and in vitro toxicological studies J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 879 2011 2704 2713
42. H. Thiermann, D. Steinritz, F. Worek, M. Radtke, P. Eyer, F. Eyer, N. Felgenhauer, and T. Zilker Atropine maintenance dosage in patients with severe organophosphate pesticide poisoning Toxicol. Lett. 206 2011 77 83
43. D. Rochu, E. Chabriere, and P. Masson Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning Toxicology 233 2007 47 59 (Pubitemid 46498378)
44. F. Brandhuber, M. Zengerle, L. Porwol, O. Tenberken, H. Thiermann, F. Worek, S. Kubik, and G. Reiter Detoxification of tabun at physiological pH mediated by substituted beta-cyclodextrin and glucose derivatives containing oxime groups Toxicology 302 2012 163 171
45. R.K. Kalakuntla, T. Wille, P.R. Le, S. Letort, G. Reiter, S. Muller, H. Thiermann, F. Worek, G. Gouhier, O. Lafont, and F. Estour New modified beta-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (I). Synthesis and preliminary screening: evaluation of the detoxification using a half-quantitative enzymatic assay Toxicol. Lett. 216 2013 200 205
46. S. Muller, M. Koller, P.R. Le, O. Lafont, F. Estour, T. Wille, H. Thiermann, F. Worek, and G. Reiter In vitro detoxification of cyclosarin (GF) by modified cyclodextrins Toxicol. Lett. 200 2011 53 58
47. S. Muller, F. Estour, R.K. Kalakuntla, P.R. Le, O. Lafont, F. Worek, H. Thiermann, and G. Reiter New modified beta-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (II). In vitro detoxification of cyclosarin (GF): general screening and toxicokinetic aspects of OP scavengers Toxicol. Lett. 216 2013 206 212
48. K. Kehe, H. Thiermann, F. Balszuweit, F. Eyer, D. Steinritz, and T. Zilker Acute effects of sulfur mustard injury-Munich experiences Toxicology 263 2009 3 8
49. K. Kehe, and H. Thiermann Clinical picture of sulfur mustard poisoning Toxicology 263 2009 1
50. K. Kehe, and L. Szinicz Medical aspects of sulphur mustard poisoning Toxicology 214 2005 198 209 (Pubitemid 41406260)
51. K. Kehe, F. Balszuweit, J. Emmler, H. Kreppel, M. Jochum, and H. Thiermann Sulfur mustard research-strategies for the development of improved medical therapy Eplasty 8 2008 e32
52. R.M. Black An overview of biological markers of exposure to chemical warfare agents J. Anal. Toxicol. 32 2008 2 9 (Pubitemid 351359056)
53. K. Kehe, F. Balszuweit, D. Steinritz, and H. Thiermann Molecular toxicology of sulfur mustard-induced cutaneous inflammation and blistering Toxicology 263 2009 12 19
54. D. Steinritz, B. Bolck, J. Schwarz, F. Balszuweit, S. Duhr, M. Ibrahim, W. Bloch, H. Thiermann, and K. Kehe Effect of N-acetyl cysteine and alpha-linolenic acid on sulfur mustard caused impairment of in vitro endothelial tube formation Toxicol. Sci. 118 2010 521 529
55. Meridian Medical Technologies™. Product overview ATNAA. Available from: < http://meridianmeds.com/products-overview-antidote.aspx >, 2013.
56. F. Balszuweit, H. John, A. Schmidt, K. Kehe, H. Thiermann, D. Steinritz., Silibinin as a potential therapeutic for sulfur mustard injuries, Chem. Biol. Interact. (2013), http://dx.doi.org/10.1016/j.cbi.2013.06.015. [Epub ahead of print].
57. M. Balali-Mood, S. Mousavi, and B. Balali-Mood Chronic health effects of sulphur mustard exposure with special reference to Iranian veterans Emerging Health Threats J. 1 2008 e7
58. M. Balali-Mood, M. Hefazi, M. Mahmoudi, E. Jalali, D. Attaran, M. Maleki, M.E. Razavi, G. Zare, A. Tabatabaee, and M.R. Jaafari Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans Fundam. Clin. Pharmacol. 19 2005 713 721 (Pubitemid 43822007)
59. E. Darchini-Maragheh, H. Nemati-Karimooy, H. Hasanabadi, and M. Balali-Mood Delayed neurological complications of sulphur mustard and tabun poisoning in 43 Iranian veterans Basic Clin. Pharmacol. Toxicol. 111 2012 426 432
60. M. Etezad-Razavi, M. Mahmoudi, M. Hefazi, and M. Balali-Mood Delayed ocular complications of mustard gas poisoning and the relationship with respiratory and cutaneous complications Clin. Exp. Ophthalmol. 34 2006 342 346 (Pubitemid 44137552)
61. M. Hefazi, M. Maleki, M. Mahmoudi, A. Tabatabaee, and M. Balali-Mood Delayed complications of sulfur mustard poisoning in the skin and the immune system of Iranian veterans 16-20 years after exposure Int. J. Dermatol. 45 2006 1025 1031 (Pubitemid 44317113)
62. M. Hefazi, D. Attaran, M. Mahmoudi, and M. Balali-Mood Late respiratory complications of mustard gas poisoning in Iranian veterans Inhalation Toxicol. 17 2005 587 592 (Pubitemid 41161312)
63. M. Mahmoudi, M. Hefazi, M. Rastin, and M. Balali-Mood Long-term hematological and immunological complications of sulfur mustard poisoning in Iranian veterans Int. Immunopharmacol. 5 2005 1479 1485 (Pubitemid 40813304)
64. A. Schmidt, M. Scherer, H. Thiermann, D. Steinritz., Mesenchymal Stem Cells are highly resistant to sulfur mustard, Chem. Biol. Interact. (2013), http://dx.doi.org/10.1016/j.cbi.2013.07.013. [Epub ahead of print].